Tender Details

Country: Canada
Summary: Appropriate Use of Prescription Medications in Dentistry
CAT Ref No: 128442501
Deadline: 07 Nov 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: C-252604420
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
An overview of our requirements is outlined below. For more information and proposal submission instructions, refer to the RFP main document. Additional instructions may get published in bulletins.On December 18th, 2023, the federal government announced the creation of Canada's Drug Agency (CDA-AMC) by building on the foundation of CADTH and in partnership with provinces and territories. With the creation of the CDA-AMC, the organization now has an expanded mandate—in addition to its core work on HTAs and clinical and cost effectiveness of new drugs—which includes appropriate prescribing and use, data and analytics, and system coordination. Specific to Appropriate Use (AU), CDA-AMC has been tasked with driving a coordinated approach and a common agenda to improve patient safety and outcomes associated with prescribing and use of medications. To do this, CDA-AMC will finalize a pan-Canadian appropriate prescribing and use strategy and develop a corresponding program. Appropriate use can be defined as follows:Appropriate use is when patients, caregivers, and health care professionals work together to choose safe and effective medications most suited for that person's needs and goals to achieve best health outcomes. This can be subdivided into three main categories consisting of overuse, underuse and inappropriate use.To support the development of its pan-Canadian Appropriate Use (AU) Program, CDA-AMC is commissioning the development of a Resource Paper that will identify key ar...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Appropriate Use of Prescription Medications in Dentistry - Canada Tender

The CANADA'S DRUG AGENCY, a Government sector organization in Canada, has announced a new tender for Appropriate Use of Prescription Medications in Dentistry. This tender is published on CanadaTenders under CAT Ref No: 128442501 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.